December 26, 2017 Comments Off on New patent expiration for Biogen Idec drug SPINRAZA Posted in: Uncategorized
Annual Drug Patent Expirations for SPINRAZA Spinraza is a drug marketed by Biogen Idec and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent expiration for Biogen Idec drug SPINRAZA appeared first on…
December 26, 2017 Comments Off on New patent expiration for Kastle Theraps drug KYNAMRO Posted in: Uncategorized
Annual Drug Patent Expirations for KYNAMRO Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. There are three patents protecting this drug. This drug…
The post New patent expiration for Kastle Theraps drug KYNAMRO appeared fir…